Do Dual-mobility Cups Reduce Revision Risk in Femoral Neck Fractures Compared With Conventional THA Designs? An International Meta-analysis of Arthroplasty Registries

• Published in: Clinical orthopaedics and related research Vol. 480; no. 10; pp. 1912 - 1925
• Main Authors: Farey, John E., Masters, James, Cuthbert, Alana R., Iversen, Pernille, van Steenbergen, Liza N., Prentice, Heather A., Adie, Sam, Sayers, Adrian, Whitehouse, Michael R., Paxton, Elizabeth W., Costa, Matthew L., Overgaard, Søren, Rogmark, Cecilia, Rolfson, Ola, Harris, Ian A.
• Format: Journal Article
• Language: English
• Published: United States Wolters Kluwer 01.10.2022; Lippincott Williams & Wilkins Ovid Technologies
• Subjects: Acetabulum; adverse device effect; adverse event; Arthroplasty; Arthroplasty, Replacement, Hip - adverse effects; Arthroplasty, Replacement, Hip - methods; Clinical Medicine; Comorbidity; femoral neck fracture; Femoral Neck Fractures; Femoral Neck Fractures - etiology; Fractures; Hip; Hip dislocation; hip fracture; Hip Fractures; Hip Fractures - etiology; hip prosthesis; Hip Prosthesis - adverse effects; hip replacement; human; Humans; Joint surgery; Klinisk medicin; Medical and Health Sciences; Medicin och hälsovetenskap; Meta-analysis; Mobility; Orthopedics; Ortopedi; Patients; procedures; Prostheses; prosthesis complication; Prosthesis Design; Prosthesis Failure; randomized controlled trial (topic); Randomized Controlled Trials as Topic; register; Registries; reoperation; Reoperation - adverse effects; Replacement; risk factor; Risk Factors; Risk groups; Selected Papers from the 10th International Congress of Arthroplasty Registries Guest Editor: Ola Rolfson Md, Phd; Surgery; Survival
• ISSN: 0009-921X; 1528-1132; 1528-1132
• DOI: 10.1097/CORR.0000000000002275

Dual-mobility cups in THA were designed to reduce prosthesis instability and the subsequent risk of revision surgery in high-risk patients, such as those with hip fractures. However, there are limited data from clinical studies reporting a revision benefit of dual-mobility over conventional THA. Collaboration between anthroplasty registries provides an opportunity to describe international practice variation and compare between-country, all-cause revision rates for dual-mobility and conventional THA. We summarized observational data from multiple arthroplasty registries for patients receiving either a dual-mobility or conventional THA to ask: (1) Is dual-mobility use associated with a difference in risk of all-cause revision surgery compared with conventional THA? (2) Are there specific patient characteristics associated with dual-mobility use in the hip fracture population? (3) Has the use of dual-mobility constructs changed over time in patients receiving a THA for hip fracture? Six member registries of the International Society of Arthroplasty Registries (from Australia, Denmark, Sweden, the Netherlands, the United Kingdom, and the United States) provided custom aggregate data reports stratified by acetabular cup type (dual-mobility or conventional THA) in primary THA for hip fracture between January 1, 2002, and December 31, 2019; surgical approach; and patient demographic data (sex, mean age, American Society of Anesthesiologists class, and BMI). The cumulative percent revision and mortality were calculated for each registry. To determine a global hazard ratio of all-cause revision for dual-mobility compared with conventional THA designs, we used a pseudoindividual patient data approach to pool Kaplan-Meier prosthesis revision data from each registry and perform a meta-analysis. The pseudoindividual patient data approach is a validated technique for meta-analysis of aggregate time-to-event survival data, such as revision surgery, from multiple sources. Data were available for 15,024 dual-mobility THAs and 97,200 conventional THAs performed for hip fractures during the study period. After pooling of complete Kaplan-Meier survival data from all six registries, the cumulative percent revision for conventional THA was 4.3% (95% confidence interval [CI] 4.2% to 4.5%) and 4.7% (95% CI 4.3% to 5.3%) for dual-mobility THA at 5 years. We did not demonstrate a lower risk of all-cause revision for patients receiving dual-mobility over conventional THA designs for hip fracture in the meta-analysis once between-registry differences were adjusted for (HR 0.96 [95% CI 0.86 to 1.06]). A lower proportion of dual-mobility procedures were revised for dislocation than conventional THAs (0.9% versus 1.4%) but a higher proportion were revised for infection (1.2% versus 0.8%). In most registries, a greater proportion of dual-mobility THA patients were older, had more comorbidities, and underwent a posterior approach compared with conventional THA (p < 0.001). The proportion of dual-mobility THA used to treat hip fractures increased in each registry over time and constituted 21% (2438 of 11,874) of all THA procedures in 2019. The proportion of dual-mobility THAs in patients with hip fractures increased over time, but there was large variation in use across countries represented here. Dual-mobility cups were not associated with a reduction in the overall risk of revision surgery in patients with hip fractures. A randomized controlled trial powered to detect the incidence of dislocation and subsequent revision surgery is required to clarify the efficacy of dual-mobility cups to treat hip fractures. Level III, therapeutic study.